Skip to main content
. 2021 Oct;62(5):446–455. doi: 10.3325/cmj.2021.62.446

Table 1.

Differences in sociodemographic and clinical characteristics of patients with pulmonary hypertension and control group*

Variable Group Median 25-75 percentile P
Age (years)*
control
58.50
48.00-66.00
0.278
PH
60.00
39.00-75.00
Smoking years (n)
control
20.00
0.00-35.75
0.651
PH
30.00
20.00-30.00
Pack per year (n)
control
35.00
0.00-52.50
0.788
PH
30.00
20.00-40.00
BMI (kg/m2)
control
27.53
26.42-30.10
0.068
PH
26.32
23.60-28.25
BSA (m2)
control
1.94
1.90-2.02
0.245
PH
1.90
1.77-2.02
Exacerbations in one year (n)
control
3.00
2.00-3.00
0.083
PH
3.00
3.00-3.75
CAT
control
28.00
24.50-31.25
0.894
PH
28.50
25.00-32.75
FVC (%)
control
59.00
40.05-78.00
0.784
PH
57.20
47.43-72.03
FEV1 (%)
control
32.50
20.43-50.00
0.551
PH
33.70
22.20-46.08
FEV1/FVC
control
45.30
35.20-65.00
0.678
PH
49.95
39.00-61.00
DLCO
control
37.50
32.50-55.00
0.090
PH
50.00
40.00-65.00
6-MWT
control
240.00
180.00-370.00
0.052
PH
182.50
125.00-267.50
BODE control
5.50
2.00-6.25
0.006
PH 6.00 4.25-7.00

*Abbreviations: PH – pulmonary hypertension; BMI – body mass index; BSA – body surface area; CAT – COPD assessment test; FVC – forced volume vital capacity; FEV1 – forced expiratory volume in 1st second; FEV1/FVC – the Tiffeneau-Pinelli index; DLCO – diffusing capacity for carbon monoxide; 6-MWT six-minute walking test; BODE – body mass index, airflow obstruction, dyspnea, and exercise.

‡Mann-Whitney U test.